Business · 1 sources covering this

Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Times of IndiaLean R·2h ago
Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive
US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028.
Read at Times of India →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/7faa7aa9355a5b414d3360a61b4d80f3916292e5"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive"></iframe>

Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

How 1 sources are covering this

Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

More from Business

Amarnath Yatra: Policeman killed in terror attack in J&K’s Anantnag, Lashkar-e-Taiba outfit claims responsibility

Boiling point? Brent crude touches five week high, here’s what analysts expect next for oil markets

Why did the stock market crash today? BSE Sensex ends over 700 points down, Nifty50 below 24,000; top reasons for fall

HUL Hikes Dove Shampoo Nearly 10%, Raises Rin Prices Up To 8% Since March

Reader

Trust & legal

Across the network

How 1 sources are covering this

Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

More from Business

Amarnath Yatra: Policeman killed in terror attack in J&amp;K’s Anantnag, Lashkar-e-Taiba outfit claims responsibility

Boiling point? Brent crude touches five week high, here’s what analysts expect next for oil markets

Why did the stock market crash today? BSE Sensex ends over 700 points down, Nifty50 below 24,000; top reasons for fall

HUL Hikes Dove Shampoo Nearly 10%, Raises Rin Prices Up To 8% Since March

Reader

Trust & legal

Across the network

Amarnath Yatra: Policeman killed in terror attack in J&K’s Anantnag, Lashkar-e-Taiba outfit claims responsibility